Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -40873.19% is 506% below its 5-year average of -6744.54%, near the low end of its 5-year range (-40873.19%–-238.14%).
269.82% below its 12-month average of -11052.13%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -9745.36%.
EBITDA MARGIN
-40873.19%
EBITDA MARGIN AVG TTM
-11052.13%
EBITDA MARGIN AVG 3Y
-11052.13%
EBITDA MARGIN AVG 5Y
-6744.54%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-269.82%
CURRENT VS 3Y AVG
-269.82%
CURRENT VS 5Y AVG
-506.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jupiter Neurosciences, Inc.
Market Cap
$1.18M
EBITDA Margin
-40873.19%
TTM Avg
-11052.13%
3Y Avg
-11052.13%
5Y Avg
-6744.54%
Market Cap
$1.19M
EBITDA Margin
-17.60%
TTM Avg
-16.25%
3Y Avg
-23.94%
5Y Avg
-32.10%
Market Cap
$1.10M
EBITDA Margin
-6.76%
TTM Avg
-0.42%
3Y Avg
7.09%
5Y Avg
7.09%
Market Cap
$1.03M
EBITDA Margin
-182712.72%
TTM Avg
-182712.72%
3Y Avg
-182712.72%
5Y Avg
-182712.72%
Market Cap
$1.41M
EBITDA Margin
-22.87%
TTM Avg
-29.13%
3Y Avg
-70.31%
5Y Avg
-127.65%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.18M | -40873.19% | -11052.13% | -11052.13% | -6744.54% |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | -17.60% | -16.25% | -23.94% | -32.10% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -6.76% | -0.42% | 7.09% | 7.09% |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.33M | N/A | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -182712.72% | -182712.72% | -182712.72% | -182712.72% |
| NewcelX Ltd. (NCEL)vs › | $1.43M | N/A | N/A | N/A | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.41M | -22.87% | -29.13% | -70.31% | -127.65% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | N/A | N/A | N/A | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.46M | -75.46% | -92.89% | -421.55% | -389.33% |
Gross Margin
88.3%
EBITDA Margin
-40873.2%
Operating Margin
-40873.2%
Net Margin
-14220.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -9745.36% |
| 2026-03-31 | -10524.34% |
| 2025-12-31 | -12886.70% |
| 2022-06-30 | -238.14% |
| 2021-06-30 | -328.18% |
| 2021-03-31 | -61.22% |
| 2020-12-31 | -44.65% |
